<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://drugnews.com.tw/articles/2026-09-27-hibsago-finite-hbv-care-en.html</loc>
    <news:news>
      <news:publication>
        <news:name>Drugnews｜藥時事</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T00:00:00.000Z</news:publication_date>
      <news:title>New Hepatitis B Drug Approved in Japan: About One in Five Treated Trial Patients Achieved a “Functional Cure”</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://drugnews.com.tw/articles/2026-09-27-hibsago-finite-hbv-care.html</loc>
    <news:news>
      <news:publication>
        <news:name>Drugnews｜藥時事</news:name>
        <news:language>zh-tw</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T00:00:00.000Z</news:publication_date>
      <news:title>B 肝新藥在日本獲准，新藥組約兩成受試者達「功能性治癒」</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://drugnews.com.tw/articles/2026-09-26-scholar-rock-isembyld-sma-care-en.html</loc>
    <news:news>
      <news:publication>
        <news:name>Drugnews｜藥時事</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T00:00:00.000Z</news:publication_date>
      <news:title>A new US therapy for muscle-wasting disease: bringing four-weekly infusions into everyday care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://drugnews.com.tw/articles/2026-09-26-scholar-rock-isembyld-sma-care.html</loc>
    <news:news>
      <news:publication>
        <news:name>Drugnews｜藥時事</news:name>
        <news:language>zh-tw</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T00:00:00.000Z</news:publication_date>
      <news:title>肌肉萎縮新藥在美獲准，每四週輸注如何走進生活？</news:title>
    </news:news>
  </url>
</urlset>
